Timothy M. Cunningham

Chief Financial Officer, Organogenesis Holdings Inc.

Companies

Neuphoria Therapeutics Inc.Chief financial officer Jul 8, 2024 to Jul 8, 2024¹
Rein Therapeutics, Inc.Officer May 16, 2024 to May 16, 2024²
Peak Bio, Inc.Chief financial officer Nov 4, 2022 to Nov 4, 2022³
ZIOPHARM OncologyChief financial officer Feb 26, 2021 to Feb 26, 2021⁴
Organogenesis Holdings Inc.Chief financial officer Dec 12, 2018 to Apr 24, 2020⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNeuphoria Therapeutics Inc., Chief financial officer
2
SEC EDGARRein Therapeutics, Inc., Officer
3
SEC EDGARPeak Bio, Inc., Chief financial officer
4
SEC EDGARZIOPHARM Oncology, Chief financial officer
5
SEC EDGAROrganogenesis Holdings Inc., Chief financial officer